These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 112217)
21. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist. Jolicoeur FB; Rivest R; St-Pierre S; Gagné MA; Dumais M Neuropeptides; 1985 Apr; 6(2):143-56. PubMed ID: 2987745 [TBL] [Abstract][Full Text] [Related]
22. Gaba(A) receptors in the pedunculopontine tegmental nucleus play a crucial role in rat shell-specific dopamine-mediated, but not shell-specific acetylcholine-mediated, turning behaviour. Ikeda H; Akiyama G; Matsuzaki S; Sato M; Koshikawa N; Cools AR Neuroscience; 2004; 125(3):553-62. PubMed ID: 15099669 [TBL] [Abstract][Full Text] [Related]
23. A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist. Patel S; Slater P; Crossman AR Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):334-40. PubMed ID: 4094623 [TBL] [Abstract][Full Text] [Related]
25. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell. Uchida T; Adachi K; Fujita S; Lee J; Gionhaku N; Cools AR; Koshikawa N Eur J Pharmacol; 2005 Mar; 510(1-2):39-47. PubMed ID: 15740723 [TBL] [Abstract][Full Text] [Related]
26. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens. Hamilton MH; De Belleroche JS; Gardiner IM; Herberg LJ Pharmacol Biochem Behav; 1986 Nov; 25(5):943-8. PubMed ID: 2878446 [TBL] [Abstract][Full Text] [Related]
27. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. Cools AR; Oosterloo SK J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148 [TBL] [Abstract][Full Text] [Related]
28. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens. Schoffelmeer AN; Wardeh G; Vanderschuren LJ Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945 [TBL] [Abstract][Full Text] [Related]
29. Uptake of gamma-aminobutyric acid by human blood platelets: comparison with CNS uptake. Hambley JW; Johnston GA Life Sci; 1985 May; 36(21):2053-62. PubMed ID: 3923286 [TBL] [Abstract][Full Text] [Related]
30. [Effect of Y-516 on the hyperactivity induced by dopamine injected bilaterally into the nucleus accumbens]. Morimoto T; Morimoto Y; Fukuda T; Setoguchi M Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):65-71. PubMed ID: 2227720 [TBL] [Abstract][Full Text] [Related]
31. Effect of picrotoxin and nipecotic acid on inhibitory response of dopaminergic neurons in the ventral tegmental area to stimulation of the nucleus accumbens. Yim CY; Mogenson GJ Brain Res; 1980 Oct; 199(2):466-73. PubMed ID: 7417797 [TBL] [Abstract][Full Text] [Related]
32. Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat. Jones DL; Mogenson GJ; Wu M Neuropharmacology; 1981 Jan; 20(1):29-37. PubMed ID: 6261181 [No Abstract] [Full Text] [Related]
33. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress. Doherty M; Gratton A Brain Res; 2007 May; 1150():62-8. PubMed ID: 17395162 [TBL] [Abstract][Full Text] [Related]
34. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat. Kafetzopoulos E Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447 [TBL] [Abstract][Full Text] [Related]
35. GABAergic mechanisms in the nucleus accumbens septi regulating rat motor activity: the effect of chronic treatment with desipramine. Płaznik A; Stefański R; Kostowski W Pharmacol Biochem Behav; 1990 Jul; 36(3):501-6. PubMed ID: 2165615 [TBL] [Abstract][Full Text] [Related]
36. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens. Brudzyński SM; Mogenson GJ Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781 [TBL] [Abstract][Full Text] [Related]
37. Uptake inhibitors potentiate gamma-aminobutyric acid-induced contractile responses in the isolated ileum of the guinea-pig. Ong J Br J Pharmacol; 1987 May; 91(1):9-15. PubMed ID: 3594086 [TBL] [Abstract][Full Text] [Related]
38. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Kolta MG; Shreve P; Uretsky NJ Neuropharmacology; 1989 Jan; 28(1):9-14. PubMed ID: 2927583 [TBL] [Abstract][Full Text] [Related]
39. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens. Boldry RC; Uretsky NJ Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677 [TBL] [Abstract][Full Text] [Related]
40. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]